Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return.
As of today, EuroEyes International Eye Clinic's Shareholder Yield % was -1.22%.
EuroEyes International Eye Clinic (HKSE:01846) Shareholder Yield % Explanation
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."
Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.
Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.
Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.
EuroEyes International Eye Clinic Shareholder Yield % Related Terms
EuroEyes International Eye Clinic Shareholder Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EuroEyes International Eye Clinic Shareholder Yield % Chart
HKSE:01846 vs HCA, THC, DVA: Shareholder Yield % Comparison
For the Medical Care Facilities subindustry, EuroEyes International Eye Clinic's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EuroEyes International Eye Clinic Shareholder Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, EuroEyes International Eye Clinic's Shareholder Yield % distribution charts can be found below:
* The bar in red indicates where EuroEyes International Eye Clinic's Shareholder Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.
EuroEyes International Eye Clinic (HKSE:01846) has a Shareholder Yield % of -1.22% as of Dec. 2025. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on EuroEyes International Eye Clinic and its competitors. According to the industry distribution chart, EuroEyes International Eye Clinic ranks #394 out of 649 companies in the Healthcare Providers & Services industry, placing it in the top 60.7%.
Is EuroEyes International Eye Clinic's Shareholder Yield % too high?
EuroEyes International Eye Clinic's current Shareholder Yield % is -1.22%. Based on the distribution chart, EuroEyes International Eye Clinic ranks #394 out of 649 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, EuroEyes International Eye Clinic has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does EuroEyes International Eye Clinic's Shareholder Yield % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, EuroEyes International Eye Clinic ranks #394 out of 649 companies for Shareholder Yield %. This places EuroEyes International Eye Clinic in the lower half of its industry. The industry median Shareholder Yield % is 0.17. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for a Healthcare Providers & Services company?
The median Shareholder Yield % among Healthcare Providers & Services companies is 0.17, based on 649 companies in the industry. Companies in the top quartile (top 25%) have a Shareholder Yield % significantly above this median, while those in the bottom quartile fall well below. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on EuroEyes International Eye Clinic and its competitors. For the Healthcare Providers & Services industry, the median Shareholder Yield % is 0.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EuroEyes International Eye Clinic's current Shareholder Yield % is -1.22%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EuroEyes International Eye Clinic stock overvalued right now?
Based on GuruFocus' analysis, EuroEyes International Eye Clinic (HKSE:01846) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$5.59, compared to a current price of HK$2.70 — trading 51.7% below its estimated fair value. The current Shareholder Yield % is -1.22%. EuroEyes International Eye Clinic's overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For EuroEyes International Eye Clinic (HKSE:01846), the current Shareholder Yield % is -1.22% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is EuroEyes International Eye Clinic (HKSE:01846) Overvalued in 2026?
Based on GuruFocus' analysis, EuroEyes International Eye Clinic stock appears to be undervalued.
The current stock price of HK$2.70 is trading 51.7% below its estimated GF Value™ of HK$5.59.
GuruFocus considers EuroEyes International Eye Clinic to be Significantly Undervalued.
Key valuation signals for HKSE:01846:
Shareholder Yield %: -1.22%
GF Value™: HK$5.59 vs. price of HK$2.70 (51.7% below fair value)
No single metric tells the full story. See the HKSE:01846 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
EuroEyes International Eye Clinic Ltd is principally engaged in the provision of vision correction services in Germany, Denmark, the UK, the PRC including Hong Kong, and Switzerland. The Group is a high-end vision correction service provider in Germany, PRC, the UK, Denmark, and Switzerland. Its vision correction services include refractive laser surgery, phakic lens surgery (ICL), lens exchange surgery, and others including PRK/LASEK and ICRS implantation. Its revenue categories include provision of vision correction services generate maximum revenue, training services, sales of pharmaceutical products and others. The Group's five reportable segments are Germany generate maximum revenue, Denmark, UK, Chinese Mainland, and Switzerland.
81GF Score
Get the complete analysis for HKSE:01846
Shareholder Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01846 has been successfully added to your 
